NovaBiotics Ltd is a clinical-stage biotechnology company founded in Aberdeen by Dr. Deborah O'Neil in 2004. The Board of Directors provides a wealth of expertise in the biotechnology and pharmaceutical sector and the science team now in place (comprising immunology, microbiology and peptide antimicrobial expertise) provides a wealth of technological know-how and skills including proven, sector-specific expertise in anti-infectives business development.

As a leading innovator in the anti-infectives space, NovaBiotics’ business model is to develop candidate therapeutics to early clinical proof of concept and out-license to or co-develop with appropriate pharmaceutical partners for further clinical development. Using informed, rational drug design principles versus high-risk screening strategies, the company has streamlined this process such that it has delivered products to clinic in less than 5 years from patent priority dates.

 

Registered in Scotland No. SC272344. Registered Address: NovaBiotics Ltd, Cruickshank Building, Craibstone, Aberdeen, AB21 9TR, UK

© NovaBiotics Ltd 2009. All Rights Reserved
Last updated 22 October, 2009